Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig
- 1 September 2018
- journal article
- conference paper
- Published by Elsevier in Toxicology Letters
- Vol. 293, 198-206
Abstract
No abstract availableKeywords
Funding Information
- UK MOD
This publication has 30 references indexed in Scilit:
- Immobilization of Russian VX skin depots by localized cooling: Implications for decontamination and medical countermeasuresToxicology Letters, 2011
- Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigsToxicology Letters, 2011
- The therapeutic use of localized cooling in the treatment of VX poisoningToxicology Letters, 2011
- Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatmentChemico-Biological Interactions, 2010
- Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pigChemico-Biological Interactions, 2010
- Management of acute organophosphorus pesticide poisoningThe Lancet, 2008
- Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: A mini reviewToxicology, 2007
- Swine models in the design of more effective medical countermeasures against organophosphorus poisoningToxicology, 2007
- Site‐specific percutaneous absorption of methyl salicylate and VX in domestic swineJournal of Applied Toxicology, 2002
- Continuous Administration of Low Dose Rates of Physostigmine and Hyoscine to Guinea-pigs Prevents the Toxicity and Reduces the Incapacitation Produced by Soman PoisoningJournal of Pharmacy and Pharmacology, 1994